Designed with your most critical patients in mind
The Nellcor™ OxySoft™ SpO2 sensor is the first pulse oximetry sensor to use a silicone adhesive to protect fragile skin and improve repositionability. It is engineered with brighter LEDs on a flexible circuit — all to help you stay connected to your patients and their data.
Nellcor™ OxySoft™ SpO2 sensor
For your most critical neonatal and adult patients, every touch has an impact on their well-being. Continuous monitoring devices should minimize impact and maximize performance.
First, we
identify the pulse
with artificial intelligence (AI).
Next, we
eliminate noise
by scrubbing the signal.
Then, we
calibrate the signal
with OxiMax™ technology.
Lastly, we
bring it together with
the Nellcor™ OxiMax™ system.
Which pulse oximetry technology performs better?
Nellcor™
pulse oximetry
What’s the fundamental tech difference?
Nellcor™ technology starts with the heart, using the pulse as the foundation. By prioritizing the pulsatile signal and locking onto the pulse, it allows tracking of moment-to-moment changes.
vs.
Masimo SET™*
pulse oximetry
What’s the fundamental tech difference?
Masimo SET™* technology prioritizes the product LED signal. By assuming that both the arterial and venous blood move, it uses an algorithm to separate the arterial signal from noise.1
Nellcor™ pulse oximetry monitoring should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.
TM* Third–party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
† Oxygen saturation accuracy can be affected by certain environmental, equipment, and patient physiologic conditions (as discussed in the operator’s manual for the monitor) that influence readings of SpO2. Please consult the instructions for use and manual for full safety information.
‡ The study (not funded by Medtronic) enrolled 146 healthy subjects in the 92-96% saturation range and examined paired readings from Nellcor™ N-595 and Masimo Radical 7™* pulse oximeters generated simultaneously. This study was not designed for head-to-head comparison of the respective devices.
§ Study objective: Compare efficacy and reliability of two pulse-oximeters (POx) (Masimo Radical-7 and Nellcor™ Oximax Bedside). Study design: Prospective observational monocentric comparative clinical study. 60 newborns included in total. Funding & conflict of interest: Authors declare no conflict of interest, Nellcor™ and Masimo provided sensors free of charge.
◊ Based on post-market surveillance which may not be indicative of clinical performance.
